Inventor · disambiguated record
Xiaoqi Chen
Also filed as: CHEN XIAOQI · COOPER ARTHUR J
46 granted patents·14 pending applications·1,150 citations·filing 1996–2023
98Inventor score
Top patents by PatentIndex Score
60 records- 0199US5914332ARetroviral protease inhibiting compoundsABBOTT LAB·Filed 1996·Granted Jun 22, 1999·201 cites·17 claims
- 0298US9573936B2Triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted Feb 21, 2017·19 cites·56 claims
- 0397US10221162B2Triazole agonists of the APJ receptorAMGEN INC·Filed 2018·Granted Mar 5, 2019·12 cites·22 claims
- 0497US10058550B2Methods of treating heart failureAMGEN INC·Filed 2017·Granted Aug 28, 2018·13 cites·81 claims
- 0597US9868721B2Triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted Jan 16, 2018·14 cites·60 claims
- 0697US9745286B2Triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted Aug 29, 2017·16 cites·52 claims
- 0797US9656998B2Intermediates for preparing triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted May 23, 2017·14 cites·16 claims
- 0897US6528513B2Pyrimidine derivativesTULARIK INC·Filed 2000·Granted Mar 4, 2003·192 cites·42 claims
- 0996US7148259B1Antibacterial agentsAMGEN INC·Filed 2006·Granted Dec 12, 2006·23 cites·10 claims
- 1096US6835726B2Pyrimidine derivativesAMGEN INC·Filed 2003·Granted Dec 28, 2004·99 cites·12 claims
- 1196US6200977B1Pyrimidine derivativesTULARIK INC·Filed 1999·Granted Mar 13, 2001·209 cites·84 claims
- 1295US9845310B2Intermediates for preparing triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted Dec 19, 2017·14 cites·16 claims
- 1395US9751864B2Methods for preparing triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted Sep 5, 2017·14 cites·28 claims
- 1495US9656997B2Triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted May 23, 2017·16 cites·46 claims
- 1594US6780858B2Antibacterial agentsTULARIK INC·Filed 2001·Granted Aug 24, 2004·35 cites·25 claims
- 1692US8623885B2Fused tricyclic dual inhibitors of CDK 4/6 and FLT3CHEN XIAOQI·Filed 2012·Granted Jan 7, 2014·44 cites·35 claims
- 1792US7375102B2Tetrahydroquinazolin-4(3H)-one-related and tetrahydropyrido[2,3-D]pyrimidin-4(3H)-one-related compounds, compositions and methods for their useAMGEN SF LLC·Filed 2005·Granted May 20, 2008·27 cites·24 claims
- 1891US7939538B2Compounds, compositions and methods for prevention and treatment of inflammatory and immunoregulatory disorders and diseasesAMGEN INC·Filed 2005·Granted May 10, 2011·20 cites·23 claims
- 1990US10150760B2Compounds for use in preparing heterocyclic triazole agonists of the APJ receptorAMGEN INC·Filed 2018·Granted Dec 11, 2018·8 cites·29 claims
- 2090US7045527B2Piperidine derivativesAMGEN INC·Filed 2003·Granted May 16, 2006·39 cites·25 claims
- 2189US9988369B2Heterocyclic triazole compounds as agonists of the APJ receptorAMGEN INC·Filed 2017·Granted Jun 5, 2018·8 cites·67 claims
- 2289US7799795B2Aryl nitrile compounds and compositions and their uses in treating inflammatory and related disordersAMGEN INC·Filed 2006·Granted Sep 21, 2010·21 cites·17 claims
- 2388US9593129B2Piperidinone derivatives as MDM2 inhibitors for the treatment of cancerAMGEN INC·Filed 2016·Granted Mar 14, 2017·5 cites·18 claims
- 2488US9296736B2Piperidinone derivatives as MDM2 inhibitors for the treatment of cancerAMGEN INC·Filed 2014·Granted Mar 29, 2016·7 cites·13 claims
- 2587US2024300892A1Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of CancerAMGEN INC·Filed 2023·Application pending·0 cites
- 2686US9376425B2Heterocyclic compounds as MDM2 inhibitors for the treatment of cancerAMGEN INC·Filed 2012·Granted Jun 28, 2016·12 cites·37 claims
- 2780US11046680B1Heteroaryl-substituted triazoles as APJ receptor agonistsAMGEN INC·Filed 2017·Granted Jun 29, 2021·2 cites·33 claims
- 2880US7572783B2Substituted benzofused heterocyclesAMGEN INC·Filed 2005·Granted Aug 11, 2009·3 cites·20 claims
- 2980US2022169611A1Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of CancerAMGEN INC·Filed 2022·Application pending·0 cites
- 3078US6284767B1Retroviral protease inhibiting compoundsABBOTT LAB·Filed 1998·Granted Sep 4, 2001·14 cites·98 claims
- 3177US7271271B2Imidazolo-related compounds, compositions and methods for their useAMGEN SF LLC·Filed 2005·Granted Sep 18, 2007·3 cites·14 claims
- 3276US10729133B2Cornfield herbicidal composition and application thereofQINGDAO KINGAGROOT RESISTANT WEED MAN CO LTD·Filed 2017·Granted Aug 4, 2020·1 cites·18 claims
- 3376US5905068ARetroviral protease inhibiting compoundsABBOTT LAB·Filed 1996·Granted May 18, 1999·21 cites·13 claims
- 3474US6472529B2Retroviral protease inhibiting compoundsABBOTT LAB·Filed 2001·Granted Oct 29, 2002·4 cites·9 claims
- 3574US2021179560A1Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of CancerAMGEN INC·Filed 2020·Application pending·0 cites
- 3671US6809104B2Fused heterocyclic compoundsTULARIK INC·Filed 2002·Granted Oct 26, 2004·4 cites·38 claims
- 3770US10736883B2Triazole furan compounds as agonists of the APJ receptorAMGEN INC·Filed 2017·Granted Aug 11, 2020·1 cites·25 claims
- 3868US7279582B2Retroviral protease inhibiting compoundsABBOTT LAB·Filed 2002·Granted Oct 9, 2007·2 cites·6 claims
- 3967US7053234B2Antibacterial agentsAMGEN INC·Filed 2004·Granted May 30, 2006·2 cites·5 claims
- 4067US2019062276A1Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of CancerAMGEN INC·Filed 2018·Application pending·0 cites
- 4165US2014011796A1Piperidinone derivatives as mdm2 inhibitors for the treatment of cancerAMGEN INC·Filed 2013·Application pending·0 cites
- 4264US7968707B2Retroviral protease inhibiting compoundsABBOTT LAB·Filed 2007·Granted Jun 28, 2011·0 cites·12 claims
- 4364US2017144971A1Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of CancerAMGEN INC·Filed 2017·Application pending·0 cites
- 4463US9359355B2Fused tricyclic dual inhibitors of CDK 4/6 and FLT3AMGEN INC·Filed 2013·Granted Jun 7, 2016·0 cites·14 claims
- 4563US7253179B2Fused heterocyclic compoundsAMGEN INC·Filed 2003·Granted Aug 7, 2007·1 cites·35 claims
- 4663US6858619B2Fused heterocyclic compoundsAMGEN INC·Filed 2002·Granted Feb 22, 2005·3 cites·47 claims
- 4762US6251906B1Retroviral protease inhibiting compoundsABBOTT LAB·Filed 1999·Granted Jun 26, 2001·7 cites·30 claims
- 4859US7125885B2Fused heterocyclic compoundsAMGEN INC·Filed 2004·Granted Oct 24, 2006·0 cites·2 claims
- 4959US2022153739A1Opioid receptor modulator and use thereofARRIBA BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 5056US2008058365A1Fused heterocyclic compoundsAMGEN INC·Filed 2007·Application pending·0 cites
Showing the top 50 of 60 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Xiaoqi Chen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →